e-learning
resources
Vienna 2012
Sunday, 02.09.2012
COPD comorbidities II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease
M. Lainscak, R. Marcun, A. Sustic, P. Mesko Brguljan, M. Kosnik, S. Kadivec, J. Farkas (Golnik, Ljubljana, Slovenia; Rijeka, Croatia)
Source:
Annual Congress 2012 - COPD comorbidities II
Session:
COPD comorbidities II
Session type:
Thematic Poster Session
Number:
554
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lainscak, R. Marcun, A. Sustic, P. Mesko Brguljan, M. Kosnik, S. Kadivec, J. Farkas (Golnik, Ljubljana, Slovenia; Rijeka, Croatia). NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2012; 40: Suppl. 56, 554
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Predictors of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation
Source: Eur Respir J 2008; 31: 563-570
Year: 2008
Troponin T elevation and one year mortality after acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009
The relationship between chronic obstructive pulmonary disease exacerbations and right ventricular function
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Resistin, 8-isorpostanes and stress right ventricular diastolic dysfunction - predictors for exacerbations in non-severe chronic obstructive pulmonary disease patients
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Prognostic value of ventricular volumes and function in patients with pulmonary hypertension due to chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
The frequency of the cardiac arrhythmias of the patients who suffer from the chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Possible mechanisms of ventricular arrhythmias in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005
Echocardiographic indices of right ventricular sizes and function in patients with moderate and severe chronic obstructive pulmonary disease, with the past history of myocardial infarction
Source: Eur Respir J 2007; 30: Suppl. 51, 127s
Year: 2007
High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Echocardiographic evaluation of right ventricular diastolic function in patients with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with cor pulmonale
Source: Eur Respir J 2004; 24: Suppl. 48, 112s
Year: 2004
Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)>
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2011 - COPD management
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept